Transversus thoracic muscle plane block for perioperative pain management and stress responses in cardiac surgery

Transversus thoracic muscle plane block and cardiac surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000038638

Enrollment

Unknown

Registered

2020-09-26

Start date

2020-10-09

Completion date

Unknown

Last updated

2020-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac surgery

Interventions

TTMP group:TTMP with ropivacaine 0.5%, 15ml

Control group:TTMP with equivalent volume of saline

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. aged between 18 and 65 years; 2. scheduled for elective cardiac valve repair or replacement surgery with cardiopulmonary bypass through median sternotomy; 3. American Society of Anesthesiologists classification II–III.

Exclusion criteria

Exclusion criteria: 1. unable to provide a signed informed consent; 2. known allergy to local anesthetics; 3. long-term use of opioids; 4. preoperative blood glucose above 180mg/dL (10mmol/L); 5. previous open cardiac surgery; 6. liver or renal dysfunction.

Design outcomes

Primary

Measure	Time frame
the interval between extubation and the first PCIA bolus injection;cumulative sufentanil consumption;postoperative VAS scores;	—

Countries

China

Contacts

Public ContactNa Jing

The First Affiliated Hospital, China Medical University

jingna2542@163.com+86 15942335877

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026